Systematic Review of the Staging Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer

…, GW Sloof, JJB Van Lanschot, H Groen… - Journal of clinical …, 2004 - ascopubs.org
Purpose Despite the increasing number of publications concerning 18 F-fluorodeoxyglucose
positron emission tomography (FDG-PET) for staging of esophageal cancer and the …

[HTML][HTML] Complication rates of CT-guided transthoracic lung biopsy: meta-analysis

WJ Heerink, GH de Bock, GJ de Jonge, HJM Groen… - European …, 2017 - Springer
Objectives To meta-analyze complication rate in computed tomography (CT)-guided transthoracic
lung biopsy and associated risk factors. Methods Four databases were searched from …

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and …

D Gilligan, M Nicolson, I Smith, H Groen, O Dalesio… - The Lancet, 2007 - thelancet.com
Background Although surgery offers the best chance of cure for patients with non-small cell
lung cancer (NSCLC), the overall 5-year survival rate is modest, and improvements are …

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

…, VM Fazio, H Groen, W Timens, H Sietsma… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …

[HTML][HTML] Reduced lung-cancer mortality with volume CT screening in a randomized trial

…, JE Walter, K Ten Haaf, HJM Groen… - New England journal …, 2020 - Mass Medical Soc
Background There are limited data from randomized trials regarding whether volume-based,
low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among …

[HTML][HTML] Preoperative staging of non–small-cell lung cancer with positron-emission tomography

…, GH Koëter, V Fidler, J Pruim, HJM Groen - … England Journal of …, 2000 - Mass Medical Soc
Background Determining the stage of non–small-cell lung cancer often requires multiple
preoperative tests and invasive procedures. Whole-body positron-emission tomography (PET) …

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

…, J Clement, H Groen, W Timens, H Sietsma… - Science translational …, 2010 - science.org
Lung cancer remains one of the leading causes of cancer-related death in developed countries.
Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to …

Multiple common variants for celiac disease influencing immune gene expression

…, S Fiatal, E Grandone, PM Green, HJM Groen… - Nature …, 2010 - nature.com
We performed a second-generation genome-wide association study of 4,533 individuals with
celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with …

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

…, RJ Mehran, AV Louie, P Balter, HJM Groen… - The lancet …, 2015 - thelancet.com
Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC)
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label …

CM Koopmans, D Bijlenga, H Groen, SMC Vijgen… - The Lancet, 2009 - thelancet.com
… on two occasions at least 6 h apart. Mild pre-eclampsia was … 6 h apart, combined with
proteinuria (two or more occurrences of protein on a dipstick, >300 mg total protein within a 24-h